(Q52045473)

English

A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).

scientific article published in February 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1). (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

phase III clinical trial

0 references

9

object named as

James R Jett

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

author name string

Jeff A Sloan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

James A Bonner

2

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Shauna L Hillman

3

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Cristine Allmer

4

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Thomas G Shanahan

5

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Burke J Brooks

6

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Randolph S Marks

7

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Delfino Vargas-Chanes

8

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

52

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

2

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

371-381

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-a-day radiation therapy for supraglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A quality-of-life-oriented endpoint for comparing therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox regression models for quality adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality adjusted survival analysis with repeated quality of life measures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring patient-centered outcomes in neurologic disease. Extending the Q-TWiST method.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Variance and sample size calculations in quality-of-life--adjusted survival analysis (Q-TWiST).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901819-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)01819-3

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/11872282

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52045473&oldid=1433702534"